Week 4: Asthma and COPD

29
Week 4: Asthma and COPD Dr Felix Woodhead Consultant Physician

description

Week 4: Asthma and COPD. Dr Felix Woodhead Consultant Physician. Obstructive Lung Disease. Reduced rate of airflow Wheeze Big lungs Asthma COPD Bronchiectasis. Delivery methods. Nebulisers Inhalers Aerosol Dry powder Proprietary types. Drugs. Bronchodilators. β 2 agonists. - PowerPoint PPT Presentation

Transcript of Week 4: Asthma and COPD

Page 1: Week 4: Asthma and COPD

Week 4: Asthma and COPDDr Felix WoodheadConsultant Physician

Page 2: Week 4: Asthma and COPD

Obstructive Lung Disease• Reduced rate of airflow• Wheeze• Big lungs• Asthma• COPD• Bronchiectasis

Page 3: Week 4: Asthma and COPD

Delivery methods• Nebulisers• Inhalers

– Aerosol– Dry powder– Proprietary types

Page 4: Week 4: Asthma and COPD

DrugsBronchodilators

Page 5: Week 4: Asthma and COPD

β2 agonists• Short-acting

– Salbutamol– Terbutaline

• Long-acting– Salmeterol– Formoterol

Page 6: Week 4: Asthma and COPD

Antimuscarinics• Short-acting

– ipratropium

• Long-acting– tiotropium

Page 7: Week 4: Asthma and COPD

Steroids• Beclomethasone (BCZ)• Budesonide• Fluticasone• Small- particle BCZ

Page 8: Week 4: Asthma and COPD

Combined agents• Seretide (Purple)

– =serevent (salmeterol) + flixotide (fluticasone)– Evohaler (MDI) or accuhaler (DPI)

• Symbicort– Oxis (formoterol) + pulmicort (budesonide)– Turbohaler (DPI)– SMART regime

Page 9: Week 4: Asthma and COPD

COPD

Page 10: Week 4: Asthma and COPD

Definition• Airflow obstruction (FEV1/FVC < 0.7)

• Usually progressive• Not fully reversible• Doesn’t change markedly over few months• Predominantly caused by cigarette smoking

• Differentiation from asthma

Page 11: Week 4: Asthma and COPD

GLOBAL INITIATIVE FOR OBSTRUCTIVE LUNG DISEASE

• FEV1 ≥ 80% - GOLD stage 1

• FEV1 = 50-79% - GOLD stage 2

• FEV1 = 30-49% - GOLD stage 3

• FEV1 < 30% - GOLD stage 4

• Stage 1 needs symptoms (asymp not COPD)• Relatively poor correlation between FEV1 & symptoms

Page 12: Week 4: Asthma and COPD

BODY MASS INDEX OBSTRUCTION DYSPNOEA EXERCISE CAPACITY

• BMI : <21 or not• Obstruction: broadly GOLD cutoffs• Dyspnoea: MRC score• Exercise tolerance: 6 minute walk test

• Composite score better than GOLD

Page 13: Week 4: Asthma and COPD

Treatment of stable diseaseNICE 2010

Page 14: Week 4: Asthma and COPD

Stop smoking!• Assess every time• Not asking is a dereliction of duty• Only intervention that changes natural history of

disease• “If you think you’re breathless now, just you wait…”• It is NEVER too late to stop smoking• Do not diagnose asthma if you think they may have

COPD

Page 15: Week 4: Asthma and COPD

Inhaled treatment• SOB/ex limitation: SABA/SAMA prn• Exacs/SOB

– LAMA (tiotropium) regardless of FEV1

– Or • LABA if FEV1 > 50%

• Combined LABA/ICS if FEV1 < 50%

• Still exacs/SOB– LAMA & Combined LABA/ICS

Page 16: Week 4: Asthma and COPD

(Home) Nebulisers• Consider in patients with distressing symptoms despite

adequate inhaled Rx• Only continue if beneficial• Side effects can occur• Takes up time• Placebo effect common

Page 17: Week 4: Asthma and COPD

Systemic treatment• Corticosteroids – avoid• Theophyllines

– Only after inhaled Rx tried, or not tolerated– Particular care in the elderly– Levels increased by macrolide/fluoroquinolone

• Mucolytics– Consider in patients with chronic productive cough– Continue only if beneficial

Page 18: Week 4: Asthma and COPD

Oxygen therapy• Role is to delay death from cor pulmonale• The breathlessness paradox

– SOB often good pO2

– Low sats, often not breathless• LTOT

– pO2 < 7.3 kPa when stable– pO2 < 8 kPa and nocturnal hypoxaemia, polycythaemia or cor

pulmonale– Needs to be used for at least 15/24 hours

• Short burst use (cylinders) – little role

Page 19: Week 4: Asthma and COPD

Acute exacerbation of COPD

Page 20: Week 4: Asthma and COPD

Definition• Sustained worsening of symptoms from usual state• Beyond daily day-day variation• Acute in onset• Often associated with

– ↑ SOB, ↑ cough, ↑ sputum volume, ↑ sputum purulence

• May require change in treatment• Occur due to precarious V/Q in bad lungs caused by

often minor stimuli

Page 21: Week 4: Asthma and COPD

Exclude• Pneumothorax• SVT• Myocardial infarction• Pulmonary oedema• Lung cancer• PE• Pneumonia (NOT ‘infective exacerbation’)

• No role for ‘CURB’ score in IECOPD (it is not pneumonia)

Page 22: Week 4: Asthma and COPD

Management• ↑ frequency of inhaled treatment (often nebulised)• Steroids for all (30 mg od 7-14/7)• Antibiotics if sputum purulent• O2 given

– With care, and control– ALWAYS Venturi acutely– Adjusted by SaO2 not patient/relative/nurse distress

– Guided later by ABGs– With NIV if needed

Page 23: Week 4: Asthma and COPD

Other issues• Like ‘breathlessness’, fear ‘comfort’• Keep calm• Do not give opiates/benzos• Get senior help if necessary• Nebulise on air, using nasal specs for sup O2

• NIV - use early• 2.5 mg salbutamol 2° better than 5 mg 4° • IV aminophyline can be useful

Page 24: Week 4: Asthma and COPD

Non-invasive ventilation• For ACUTE ventilatory failure• Treats ↓ pH• Allows ↑ FiO2 without ↑ pCO2

• Only suitable if conscious and protecting airway• ↑EPAP (PEEP) useful in pulm oedema and obesity• NOT poor man’s ITU• NO ROLE IN ACUTE ASTHMA/pneumonia

Page 25: Week 4: Asthma and COPD

Asthma

Page 26: Week 4: Asthma and COPD

Principles• Variable airflow obstruction• Cough and wheeze• Nocturnal features• Specific (allergic) triggers• Non-specific triggers• Eosinophils in airways• Responds to steroids

Page 27: Week 4: Asthma and COPD

Acute severe asthma• PEFR 50-33%• RR ≥ 25• HR ≥ 110• Unable to complete sentences• But SpO2 >92%

• Worse = life-threatening (silent chest, cynanosis, low SpO2)

• Better = moderate asthma

Page 28: Week 4: Asthma and COPD

Treatment• Steroids• O2

• Nebs driven with O2

• ABG if low sats or drowsy– Normal pCO2 is a sign of bad prognosis

• Senior review • Increase inhaled treatment/start it. Educate. Inhaler

technique• Consider IV bronchodilators

Page 29: Week 4: Asthma and COPD

Stable asthma• Steroids

– Inhaled best– Systemic if admission on the cards

• Step 1: SABA only • Step 2: SABA & ICS 200-800 mcg/day• Step 3: add LABA (combined)• Step 4: ↑ ICS dose (stop LABA if no benefit)• Step 5: help! Montelukast etc, aminophylline• Steroids – psychosocial issues?